While circulating C3 and C4 levels are elevated in people with diabetes, hyperglycaemia leads to an altered structure of C3 and inhibits C3-mediated complement effectors, leading to inhibited immune control of bacterial infections [51]. The gene discussed is C3; the disease is Hyperglycemia.